Apellis Pharmaceuticals has been granted a patent for a method of treating chronic respiratory disorders and other chronic complement-mediated disorders. The method involves administering multiple ...
Cp40 is a 14-amino acid cyclic analog of the peptidic complement inhibitor compstatin that binds with sub-nanomolar affinity to complement component C3 and has already shown promise in various models ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results